Metropolitan Life Insurance Company (MetLife)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,731
Closed -$24.7K 2282
2024
Q1
$24.7K Hold
2,731
﹤0.01% 1755
2023
Q4
$29.7K Hold
2,731
﹤0.01% 1726
2023
Q3
$22K Hold
2,731
﹤0.01% 1846
2023
Q2
$29.7K Buy
+2,731
New +$29.7K ﹤0.01% 1723
2022
Q2
Sell
-2,539
Closed -$23.7K 2452
2022
Q1
$23.7K Sell
2,539
-3,581
-59% -$33.5K ﹤0.01% 2011
2021
Q4
$72.7K Sell
6,120
-667
-10% -$7.92K ﹤0.01% 2623
2021
Q3
$77.2K Sell
6,787
-4,049
-37% -$46.1K ﹤0.01% 2656
2021
Q2
$194K Buy
10,836
+3,578
+49% +$64.2K ﹤0.01% 2160
2021
Q1
$112K Sell
7,258
-949
-12% -$14.7K ﹤0.01% 2372
2020
Q4
$100K Hold
8,207
﹤0.01% 2359
2020
Q3
$105K Buy
8,207
+678
+9% +$8.71K ﹤0.01% 2188
2020
Q2
$76.5K Buy
+7,529
New +$76.5K ﹤0.01% 2402
2018
Q4
Sell
-3,382
Closed -$135K 2580
2018
Q3
$135K Buy
+3,382
New +$135K ﹤0.01% 2268